GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » ROE % Adjusted to Book Value

Zhaoke Ophthalmology (HKSE:06622) ROE % Adjusted to Book Value : -21.06% (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Zhaoke Ophthalmology ROE % Adjusted to Book Value?

Zhaoke Ophthalmology's ROE % for the quarter that ended in Jun. 2024 was -7.37%. Zhaoke Ophthalmology's PB Ratio for the quarter that ended in Jun. 2024 was 0.35. Zhaoke Ophthalmology's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 was -21.06%.

Zhaoke Ophthalmology ROE % Adjusted to Book Value Historical Data

The historical data trend for Zhaoke Ophthalmology's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Zhaoke Ophthalmology ROE % Adjusted to Book Value Chart

Zhaoke Ophthalmology Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
ROE % Adjusted to Book Value
Get a 7-Day Free Trial - -237.83 -25.43 -18.04 -36.00

Zhaoke Ophthalmology Semi-Annual Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -31.63 -24.65 -14.73 -21.06 -49.61

Competitive Comparison of Zhaoke Ophthalmology's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Zhaoke Ophthalmology's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhaoke Ophthalmology's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhaoke Ophthalmology's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Zhaoke Ophthalmology's ROE % Adjusted to Book Value falls into.


;
;

Zhaoke Ophthalmology ROE % Adjusted to Book Value Calculation

Zhaoke Ophthalmology's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-17.32% / 0.96
=-18.04%

Zhaoke Ophthalmology's ROE % Adjusted to Book Value for the quarter that ended in Jun. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=-7.37% / 0.35
=-21.06%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Zhaoke Ophthalmology ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Zhaoke Ophthalmology's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Zhaoke Ophthalmology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Zhaoke Ophthalmology Ltd (HKSE:06622) » Definitions » ROE % Adjusted to Book Value
Comparable Companies
HKSE:06998 HKSE:02496 HKSE:01244 HKSE:02511 HKSE:01875 HKSE:03681 HKSE:02126 HKSE:06628 HKSE:02898 HKSE:02185 VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN
Website
https://www.zkoph.com
Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company. It is dedicated to the research, development, and commercialization of therapies that address unmet medical needs in China. The company has built a comprehensive ophthalmic drug pipeline of 26 candidates that covers ocular indications affecting the front and the back of the eye, through either in-house development or in-licensing. It has also established an ophthalmic manufacturing facility and is assembling an experienced marketing team in anticipation of a near-term product launch.
Executives
Gic Private Limited 2201 Interest of corporation controlled by you
Mak Siu Hang Viola 2201 Interest of corporation controlled by you
Apstar Investment Pte Ltd 2201 Interest of corporation controlled by you
Coyote Investment Pte Ltd 2101 Beneficial owner
Gic (ventures) Pte. Ltd. 2201 Interest of corporation controlled by you
Gic Special Investments Private Limited 2102 Investment manager
Fidelity China Special Situations Plc 2101 Beneficial owner
Fil Limited 2201 Interest of corporation controlled by you
Pandanus Associates Inc. 2201 Interest of corporation controlled by you
Pandanus Partners L.p. 2201 Interest of corporation controlled by you
Citigroup Inc. 2502 Approved lending agent
Vms Holdings Limited 2201 Interest of corporation controlled by you
Lee's Pharmaceutical Holdings Limited 2201 Interest of corporation controlled by you
Tpg Asia Genpar Vii, L.p. 2201 Interest of corporation controlled by you
Tpg Holdings Iii-a, L.p. 2201 Interest of corporation controlled by you

Zhaoke Ophthalmology Headlines

No Headlines